The New York Times reports:
The European Union is considering whether to follow the Biden administration’s decision to support a waiver of patent rights for Covid-19 vaccines as many poor and middle-income nations struggle to secure lifesaving doses.
The European Commission’s president, Ursula von der Leyen, stopped short of outright supporting President Biden in a speech on Thursday morning, but said the European Union was “also ready to discuss any proposals that address the crisis in an effective and pragmatic manner.”
“That is why we are ready to discuss how the U.S. proposal for a waiver on intellectual property protections for Covid-19 vaccines could help achieve that objective,” she said, speaking at the Florence European University Institute.
Read the full article.
The E.U. is considering whether to follow the Biden administration in supporting a waiver of patent rights for Covid-19 vaccines as poorer nations struggle to secure doses. https://t.co/ETUAbADZLO
— The New York Times (@nytimes) May 6, 2021